LACOG 0319

OC Oncoclínicas NOB

Head and neck

Quality of Life Assessment Study in Patients with Metastatic Head and Neck Neoplasia submitted to Immunotherapy in Brazil – LACOG 0319


OC Oncoclínicas NOB

Principal investigator

André Barcelar



(71) 98314-0522/71 e 4009-7085/7086/7087

Inclusion criteria

Patients diagnosed with recurrent or metastatic epidermoid carcinoma of the head and neck region, whose disease has progressed up to 6 months from the beginning of the last cycle of systemic treatment with platinum, and who are using immunotherapy (nivolumab);

Patients with primary tumors of the pharynx (oro or hypopharynx), oral cavity and larynx;


Juliana Cardoso
Or share the link
Link copied to your desktop.